Cambiar Investors LLC Invests $15.23 Million in Haleon plc (NYSE:HLN)

Cambiar Investors LLC bought a new stake in shares of Haleon plc (NYSE:HLN - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 1,849,972 shares of the company's stock, valued at approximately $15,225,000.

Several other hedge funds have also bought and sold shares of HLN. Ironwood Wealth Management LLC. bought a new stake in Haleon during the third quarter valued at approximately $70,000. Tower Research Capital LLC TRC purchased a new position in shares of Haleon during the third quarter worth approximately $115,000. Credit Suisse AG purchased a new position in shares of Haleon during the third quarter worth approximately $76,000. Guggenheim Capital LLC purchased a new position in shares of Haleon during the third quarter worth approximately $119,000. Finally, BlackRock Inc. purchased a new position in shares of Haleon during the third quarter worth approximately $10,366,000. 6.67% of the stock is currently owned by institutional investors.

Haleon Trading Up 0.7 %

Shares of NYSE HLN traded up $0.06 during mid-day trading on Friday, hitting $8.29. The stock had a trading volume of 6,191,687 shares, compared to its average volume of 8,991,846. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.73 and a current ratio of 1.04. Haleon plc has a 1 year low of $7.70 and a 1 year high of $9.05. The business has a 50 day moving average price of $8.33 and a two-hundred day moving average price of $8.30. The firm has a market cap of $37.85 billion, a P/E ratio of 29.61, a price-to-earnings-growth ratio of 2.17 and a beta of 0.29.

Haleon Dividend Announcement

The company also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be paid a $0.1064 dividend. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon's payout ratio is 75.00%.

Wall Street Analysts Forecast Growth

Separately, Argus reissued a "buy" rating on shares of Haleon in a research note on Tuesday, March 26th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.